STERIS CapEx increased by 14.1% to $98.70M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 10.7%, from $89.20M to $98.70M. Over 3 years (FY 2022 to FY 2025), CapEx shows an upward trend with a 8.8% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $56.40M | $76.97M | $81.12M | $73.07M | $115.93M | $82.77M | $91.82M | $71.45M | $66.60M | $83.29M | $118.94M | $91.50M | $108.10M | $101.90M | $89.20M | $70.89M | $93.60M | $86.50M | $98.70M |
| QoQ Change | — | +36.5% | +5.4% | -9.9% | +58.7% | -28.6% | +10.9% | -22.2% | -6.8% | +25.1% | +42.8% | -23.1% | +18.1% | -5.7% | -12.5% | -20.5% | +32.0% | -7.6% | +14.1% |
| YoY Change | — | — | — | — | +105.6% | +7.5% | +13.2% | -2.2% | -42.6% | +0.6% | +29.5% | +28.1% | +62.3% | +22.3% | -25.0% | -22.5% | -13.4% | -15.1% | +10.7% |
| Segment | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 |
|---|---|---|---|---|---|---|---|---|
| Applied Sterilization Technologies | $59.25M | $63.40M | $54.20M | $63.90M | $45.75M | $49.20M | $74.10M | $55.70M |
| Healthcare Products and Life Sciences | $28.54M | $44.60M | $47.80M | $25.30M | — | — | — | — |
| Total | $91.50M | $108.10M | $101.90M | $89.20M | $70.89M | $93.60M | $86.50M | $98.70M |